ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 58 filers reported holding ANNOVIS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,900 | -33.6% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $142,900 | -7.3% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $154,100 | +14.7% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $134,300 | -2.0% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $137,000 | +21.2% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $113,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $134,000 | -23.9% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $176,000 | -65.8% | 10,000 | -38.3% | 0.01% | -68.8% |
| Q3 2021 | $514,000 | -62.5% | 16,200 | +1.2% | 0.02% | -61.0% |
| Q2 2021 | $1,369,000 | +390.7% | 16,000 | +60.0% | 0.04% | +355.6% |
| Q1 2021 | $279,000 | +272.0% | 10,000 | 0.0% | 0.01% | +350.0% |
| Q4 2020 | $75,000 | +56.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $48,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | +46.7% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $30,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 48,941 | $464,450 | 0.22% |
| Redmond Asset Management, LLC | 34,080 | $323,419 | 0.12% |
| Sterling Investment Advisors, Ltd. | 34,374 | $326,209 | 0.11% |
| Wescott Financial Advisory Group, LLC | 41,607 | $394,850 | 0.07% |
| Worth Venture Partners, LLC | 12,321 | $116,926 | 0.07% |
| Koshinski Asset Management, Inc. | 15,000 | $142,350 | 0.02% |
| Merit Financial Group, LLC | 41,200 | $390,988 | 0.01% |
| FNY Investment Advisers, LLC | 1,133 | $10 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $2,847,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $223,964 | 0.01% |